Psoriasis treatment continues to evolve, and March 2026 brought another option for patients who need more than topical therapy. The U.S. Food and Drug Administration approved Icotyde (icotrokinra) for certain adults and adolescents with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
New treatment approvals can be exciting, but they also create a lot of questions. What kind of medication is it? Who might be a candidate? And where does an oral treatment fit among creams, phototherapy, injections, and other systemic medications?
Q: What is Icotyde?
A: Icotyde is the brand name for icotrokinra. It is an oral medication that blocks signaling through the interleukin-23, or IL-23, receptor pathway. IL-23 is one of the immune pathways involved in the inflammation that drives plaque psoriasis.
Unlike injectable biologic medications that target related immune pathways, Icotyde is taken as a tablet once daily.
Q: Who is it FDA approved for?
A: The FDA approved Icotyde in March 2026 for adults and pediatric patients age 12 and older who weigh at least 40 kilograms and have moderate-to-severe plaque psoriasis and are candidates for systemic therapy or phototherapy.
That does not mean every patient with psoriasis needs an oral systemic medication. Treatment depends on the extent of the disease, where the plaques are located, how much symptoms affect daily life, previous treatments, other medical conditions, and patient preference.
Q: What does “moderate-to-severe” psoriasis really mean?
A: Dermatologists look at more than the percentage of skin involved. A relatively small amount of psoriasis can still have a major effect when it involves the scalp, hands, feet, nails, face, or genital area. Itch, pain, cracking, bleeding, sleep disruption, work limitations, and quality of life all matter.
If topical medications are not controlling the condition—or if psoriasis is widespread or affecting high-impact areas—it may be time to discuss phototherapy or systemic treatment.
Q: How does an oral medication compare with biologic injections?
A: There is no single “best” psoriasis medication for every patient. Oral therapies may appeal to people who prefer a pill rather than an injection. Biologics can offer highly targeted immune treatment and remain an important option for many patients. Phototherapy can also be an effective non-systemic choice, particularly when the pattern and distribution of psoriasis are a good fit.
The decision should be individualized. A dermatologist can compare expected benefits, safety considerations, dosing, monitoring, medical history, insurance coverage, and lifestyle before choosing a treatment.
Q: Does a new medication mean older treatments are obsolete?
A: No. Psoriasis treatment is increasingly about matching the right therapy to the right patient. Topical medications remain appropriate for many people. Narrowband UVB and targeted Excimer laser treatment remain useful. Traditional oral medications and injectable biologics remain important options as well.
Having another FDA-approved therapy expands the conversation; it does not replace the rest of the treatment toolbox.
Q: When should I reconsider my current psoriasis treatment?
A: It may be worth discussing a change if you are still having frequent flares, plaques are not clearing adequately, side effects are limiting your current treatment, or psoriasis is interfering with sleep, exercise, work, clothing choices, or confidence.
It is also important to tell your clinician about joint pain, morning stiffness, swollen fingers or toes, or heel pain. Psoriasis can be associated with psoriatic arthritis, and those symptoms may influence treatment selection.
At Borealis Dermatology, psoriasis care can include topical therapy, systemic medications, biologic therapy, and phototherapy depending on the individual patient. Learn more about our psoriasis services.
Borealis Dermatology sees patients in Garden City, Syosset, and Bellerose, NY. Visit our locations page or Book Appointment.
Continue reading about NB-UVB versus Excimer laser treatment for psoriasis.